- Home
- ITRM vs NXN Comparison
ITRM vs NXN Comparison
Compare ITRM & NXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- NXN
- Stock Information
- Founded
- ITRM 2015
- NXN 1992
- Country
- ITRM Ireland
- NXN United States
- Employees
- ITRM N/A
- NXN N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- NXN Trusts Except Educational Religious and Charitable
- Sector
- ITRM Health Care
- NXN Finance
- Exchange
- ITRM Nasdaq
- NXN Nasdaq
- Market Cap
- ITRM 40.0M
- NXN 45.4M
- IPO Year
- ITRM 2018
- NXN N/A
- Fundamental
- Price
- ITRM $0.68
- NXN $11.95
- Analyst Decision
- ITRM Strong Buy
- NXN
- Analyst Count
- ITRM 2
- NXN 0
- Target Price
- ITRM $7.00
- NXN N/A
- AVG Volume (30 Days)
- ITRM 749.8K
- NXN 9.7K
- Earning Date
- ITRM 11-13-2025
- NXN 01-01-0001
- Dividend Yield
- ITRM N/A
- NXN 4.23%
- EPS Growth
- ITRM N/A
- NXN N/A
- EPS
- ITRM N/A
- NXN 0.24
- Revenue
- ITRM N/A
- NXN N/A
- Revenue This Year
- ITRM N/A
- NXN N/A
- Revenue Next Year
- ITRM $249.35
- NXN N/A
- P/E Ratio
- ITRM N/A
- NXN $48.42
- Revenue Growth
- ITRM N/A
- NXN N/A
- 52 Week Low
- ITRM $0.61
- NXN $10.64
- 52 Week High
- ITRM $3.02
- NXN $12.45
- Technical
- Relative Strength Index (RSI)
- ITRM 43.17
- NXN 63.74
- Support Level
- ITRM $0.61
- NXN $11.73
- Resistance Level
- ITRM $0.76
- NXN $12.02
- Average True Range (ATR)
- ITRM 0.05
- NXN 0.11
- MACD
- ITRM 0.01
- NXN 0.02
- Stochastic Oscillator
- ITRM 49.65
- NXN 80.00
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About NXN Nuveen New York Select Tax-Free Income Portfolio
Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.